HTA
AMGN icon

Haber Trilix Advisors’s Amgen AMGN Stock Holding History

Haber Trilix Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$104K Buy
+1,050
New +$109K 0.01% 177

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Haber Trilix Advisors's AMGN Position: Q2 2013 in Review

Haber Trilix Advisors opened a new position in Amgen (AMGN) in Q2 2013: 1,050 shares worth $104K. The stake represents 0.01% of the portfolio and ranks #177 among its holdings.

1,032 funds tracked by Wall St. Rank hold AMGN as of Q2 2013.

  • Haber Trilix Advisors held 1,050 shares of Amgen worth $104K as of Q2 2013.
  • Amgen was a new Haber Trilix Advisors position in Q2 2013.
  • Amgen made up 0.01% of Haber Trilix Advisors's portfolio in Q2 2013, its #177 holding.
  • 1,032 funds tracked by Wall St. Rank held Amgen as of Q2 2013.

Based on Haber Trilix Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.